Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.33M | 10.00M | 12.05M | 10.79M | 12.36M |
| Total Receivables | 228.10K | 216.50K | 431.30K | 642.90K | 286.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 219.70K | 197.60K | 234.40K | 77.80K | 112.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.78M | 10.42M | 12.72M | 11.51M | 12.76M |
|
|
|||||
| Total Current Assets | 10.78M | 10.42M | 12.72M | 11.51M | 12.76M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.90M | 1.93M | 1.95M | 1.98M | 2.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.10K | 39.90K | 40.60K | 40.00K | 40.70K |
| Total Assets | 12.72M | 12.38M | 14.71M | 13.53M | 14.80M |
|
|
|||||
| Total Accounts Payable | 3.91M | 2.19M | 756.20K | 1.08M | 672.70K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.91M | 2.19M | 756.20K | 1.08M | 672.70K |
|
|
|||||
| Total Current Liabilities | 3.91M | 2.19M | 756.20K | 1.08M | 672.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.91M | 2.19M | 756.20K | 1.08M | 672.70K |
|
|
|||||
| Common Stock & APIC | 78.45M | 74.46M | 73.02M | 69.27M | 68.68M |
| Retained Earnings | -77.90M | -72.45M | -68.20M | -65.91M | -63.65M |
| Treasury Stock & Other | -158.50K | -186.10K | -171.10K | -165.80K | -123.10K |
| Total Common Equity | 399.00K | 1.82M | 4.66M | 3.19M | 4.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.41M | 8.37M | 9.30M | 9.26M | 9.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.41M | 8.37M | 9.30M | 9.26M | 9.22M |
|
|
|||||
| Total Common Equity | 399.00K | 1.82M | 4.66M | 3.19M | 4.91M |
| Total Preferred Equity | 8.41M | 8.37M | 9.30M | 9.26M | 9.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.81M | 10.20M | 13.95M | 12.45M | 14.13M |
|
|
|||||